Exane Derivatives’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,606
Closed -$130K 1050
2021
Q1
$130K Sell
4,606
-893
-16% -$25.2K 0.04% 366
2020
Q4
$180K Sell
5,499
-2,085
-27% -$68.1K 0.05% 316
2020
Q3
$232K Buy
7,584
+275
+4% +$8.43K 0.07% 185
2020
Q2
$119K Sell
7,309
-2,396
-25% -$39.1K 0.03% 256
2020
Q1
$96.6K Buy
+9,705
New +$96.6K 0.03% 266